Tag: Novartis

Playing with consumers’ health: game over?

When you can’t access a drug treatment because of its price, you’ve probably run out of options. This is what happened some years ago to some patients affected by a severe eye disease [1]. They were denied treatment due to...

/ May 3, 2017